Center for Alcohol and Addiction Studies
Providence, Rhode Island, 02912, United States
NCT Number: NCT04071119
This proposed research seeks to examine the behavioral and neural substrates of intranasal oxytocin compared to placebo on alcohol cue-induced alcohol and cigarette craving smokers with an alcohol use disorder (AUD). Non treatment-seeking smokers with an AUD will be recruited to participate in a between-subjects, placebo-controlled, randomized pilot functional magnetic resonance imaging (fMRI) study. Participants will undergo an fMRI scan in conjunction with an alcohol-olfactory cue-reactivity task. Secondary assessments will include alcohol and cigarette craving, alcohol and cigarette consumption, physiological measures (heart rate and blood pressure) and mood measures.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Phase 1
Providence, Rhode Island, 02912, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants administer the oxytocin (40 IU) twice a day for 5 - 7 days
Participants administer the placebo (40 IU) twice a day for 5 - 7 days
Time frame: 1 day
average alcohol craving during the cue-reactivity task
Time frame: 1 day
average cigarette craving during the cue-reactivity task
Time frame: 1 day
BOLD response when comparing alcohol to neutral cues during fMRI
Time frame: 5-7 days
alcohol and cigarette consumption assessed by the Timeline Followback
Brown University
Other
The Neural Mechanisms Associated With Alcohol and Cigarette Craving in Alcohol Use Disorder Smokers During Oxytocin Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01442753
Alcohol Drinking, Alcohol Use Disorder
Minneapolis, Minnesota, United States
View Trial DetailsNCT06552741
Alcohol Use Disorder, Alcohol-Related Disorders
Baltimore, Maryland, United States
View Trial DetailsNCT04523922
Alcohol Use Disorder, Alcohol-Related Disorders
Charleston, South Carolina, United States
View Trial DetailsNCT06817356
Alcohol Use Disorder, Alcohol-Related Disorders
Scottsdale, Arizona, United States
View Trial Details